Intended for healthcare professionals


The great medicines scandal: Access is not just about cost

BMJ 2006; 333 doi: (Published 29 June 2006) Cite this as: BMJ 2006;333:44
  1. Brenda J Waning (, assistant professor of international health
  1. Boston University School of Public Health, Boston, MA 02118, USA

    EDITOR—I write with reference to the editorial by Richards.1 In addition to important information on pricing, the World Health Organization/Health Action International report provides vital information on the availability of medicines in low resource settings. The authors report alarmingly low availability of key medicines to treat chronic diseases in both public and private pharmacies across most regions.

    For example, hydrochlorothiazide, …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription